Discover What's New in Our World
Stay informed on innovation, patient outcomes, and industry trends.
Tags
Other PROMs
Home > Orthopedic Specialties & Service > Hip >EORTC QLQ-BM22
EORTC QLQ-BM22
(Bone Metastases Module)
Focus:
The EORTC QLQ-BM22 measures health-related quality of life in cancer patients with bone metastases, focusing on pain, physical function, and psychosocial concerns.
Relevant Survey:
- Body Part: Skeletal System (Bone Metastases)
- Area Of Focus: Bone Pain, Physical Function, Psychosocial Impact in Oncology
The QLQ-BM22 is a validated PROM designed as a disease-specific module to supplement the QLQ-C30 in patients with bone metastases.
Description:
The QLQ-BM22 was developed by the European Organisation for Research and Treatment of Cancer to capture issues specific to bone metastases. It measures pain sites, functional impairment, and psychosocial effects of bone involvement. Combined with the QLQ-C30, it provides a comprehensive assessment of cancer patients with metastatic disease.
Use Cases:
- Assessing quality of life in patients with bone metastases.
- Evaluating outcomes of palliative radiation or systemic therapy.
- Clinical trials targeting bone-directed cancer treatments.
- Monitoring pain and function in advanced oncology patients.
- Supporting palliative care planning.
Number Of Questions:
22
Click here to view the questionnaire.
Questionnaire Survey Consists of:
22 items across 4 scales:
- Painful Sites
- Pain Characteristics
- Functional Interference
- Psychosocial Aspects
Related articles
